Cargando…

Effects of a Water-Soluble Cinnamon Extract on Body Composition and Features of the Metabolic Syndrome in Pre-Diabetic Men and Women

PURPOSE: The purpose of this study was to determine the effects of supplementation with a water-soluble cinnamon extract (Cinnulin PF(®)) on body composition and features of the metabolic syndrome. METHODS: Twenty-two subjects with prediabetes and the metabolic syndrome (mean ± SD: age, BMI, systoli...

Descripción completa

Detalles Bibliográficos
Autores principales: Ziegenfuss, Tim N, Hofheins, Jennifer E, Mendel, Ronald W, Landis, Jamie, Anderson, Richard A
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2006
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2129164/
https://www.ncbi.nlm.nih.gov/pubmed/18500972
http://dx.doi.org/10.1186/1550-2783-3-2-45
Descripción
Sumario:PURPOSE: The purpose of this study was to determine the effects of supplementation with a water-soluble cinnamon extract (Cinnulin PF(®)) on body composition and features of the metabolic syndrome. METHODS: Twenty-two subjects with prediabetes and the metabolic syndrome (mean ± SD: age, BMI, systolic blood pressure [SBP], fasting blood glucose [FBG]: 46.0 ± 9.7 y; 33.2 ± 9.3 kg/m(2); 133 ± 17 mm Hg; 114.3 ± 11.6 mg/dL) were randomly assigned to supplement their diet with either Cinnulin PF(® )(500 mg/d) or a placebo for 12-weeks. Main outcome measures were changes in FBG, SBP, and body composition measured after 12-weeks of supplementation. The primary statistical analyses consisted of two factor (group × time), repeated-measures ANOVA for between group differences over time. In all analyses, an intent-to-treat approach was used and significance was accepted at P < 0.05. RESULTS: Subjects in the Cinnulin PF(® )group had significant decreases in FBG (-8.4%: 116.3 ± 12.8 mg/dL [pre] to 106.5 ± 20.1 mg/dL [post], p < 0.01), SBP (-3.8%: 133 ± 14 mm Hg [pre] to 128 ± 18 mm Hg [post], p < 0.001), and increases in lean mass (+1.1%: 53.7 ± 11.8 kg [pre] to 54.3 ± 11.8 kg [post], p < 0.002) compared with the placebo group. Additionally, within-group analyses uncovered small, but statistically significant decreases in body fat (-0.7%: 37.9 ± 9.2% [pre] to 37.2 ± 8.9% [post], p < 0.02) in the Cinnulin PF(® )group. No significant changes in clinical blood chemistries were observed between groups over time. CONCLUSION: These data support the efficacy of Cinnulin PF(® )supplementation on reducing FBG and SBP, and improving body composition in men and women with the metabolic syndrome and suggest that this naturally-occurring spice can reduce risk factors associated with diabetes and cardiovascular diseases.